Found: 9
Select item for more details and to access through your institution.
Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.586885
- By:
- Publication type:
- Article
Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01041
- By:
- Publication type:
- Article
Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00150
- By:
- Publication type:
- Article
Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00080
- By:
- Publication type:
- Article
Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00002
- By:
- Publication type:
- Article
Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 12, p. 1, doi. 10.1038/s41419-019-2154-4
- By:
- Publication type:
- Article
miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00060
- By:
- Publication type:
- Article
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01398
- By:
- Publication type:
- Article
Survivin Promotes Piperlongumine Resistance in Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01345
- By:
- Publication type:
- Article